$IOVA Some observations after checking Fintel's reported institutional ownership: - Institutional ownership is now 73.22% (the previously reported figure was in the mid-to-high 60%) - In June, the weight that these EFTs assigned to Iovance was adjusted: most added a substantial but not impressive

$IOVA Some observations after checking Fintel's reported institutional ownership: - Institutional ownership is now 73.22% (the previously reported figure was in the mid-to-high 60%) - In June, the weight that these EFTs assigned to Iovance was adjusted: most added a substantial but not impressive

$IOVA breaking out on large volume. Small cap biotech with a genuinely EFFECTIVE late stage metastatic melanoma treatment which is already approved by the FDA & Australia. @IovanceBio furthermore has impending solid tumor data, including comprehensive NSCLC data due bf end of year...ancedoctal evide